Elucidating the Inability of Functionalized Nanoparticles to Cross the Blood–Brain Barrier and Target Specific Cells in Vivo-Reference-Cited by-同舟云学术

Elucidating the Inability of Functionalized Nanoparticles to Cross the Blood–Brain Barrier and Target Specific Cells in Vivo

Published:2019-05-31 Issue:25 Volume:11 Page:22085-22095
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Naidu Priya S. R.,Gavriel Nikolas,Gray Chloe G. G.,Bartlett Carole A.,Toomey Lillian M.,Kretzmann Jessica A.,Patalwala Diana,McGonigle Terence¹,Denham Eleanor¹,Hee Charmaine,Ho Diwei,Taylor Nicolas L.^ORCID,Norret Marck,Smith Nicole M.^ORCID,Dunlop Sarah A.,Iyer K. Swaminathan^ORCID,Fitzgerald Melinda¹²^ORCID

Affiliation:

1. Curtin Health Innovation Research Institute, Curtin University, Bentley 6102, Australia

2. Perron Institute for Neurological and Translational Science, Ralph and Patricia Sarich Neuroscience Research Institute Building, Verdun Street, Nedlands 6009, Western Australia, Australia

Funder

National Health and Medical Research Council

Cancer Council Western Australia

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.9b01356

Reference69 articles.

1. Drug Delivery to the Central Nervous System

2. Changes in blood-brain barrier permeability to large and small molecules following traumatic brain injury in mice